3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
2
Recruiting
2
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Interventions
Lenalidomide
4
Rituximab
3
zanubrutinib
2
tafasitamab
2
fludarabine
2
Magnetic Resonance Spectroscopy
2
Cyclophosphamide
2
vorasidenib
1
tislelizumab
1
resiniferatoxin
1
relmacabtagene autoleucel
1
pomalidomide
1
orelabrutinib
1
obinutuzumab
1
loncastuximab tesirine
1
duvelisib
1
Transurethral Resection of Bladder
1
Temozolomide
1
Standard of Care
1
Spinal Puncture
1
Specimen Handling
1
Radiotherapy, Intensity-Modulated
1
Prednisone
1
Oxygen Consumption
1
Interleukin-2
1
Inhalation
1
Furosemide
1
Eflornithine
1
Diet
1
Bendamustine Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Lymphoma, Follicular
×
loncastuximab tesirine
×
Clear all
NCT07197307
2025-09-29
CLEAR
Universität Münster
Phase 2
Not yet recruiting
120 enrolled